@FiercePharma: Breast cancer patients press FDA to keep Avastin. Article | Follow @FiercePharma
> Merck & Co expects to grow as fast or faster than China's broader pharmaceutical market, now expanding by more than 20 percent each year, as Beijing rolls out a new healthcare system and an emerging middle class spends more money on medicine. Story
> An oil major, a luxury cosmetics company and independent Sanofi-Aventis directors including a former astronaut will have a key say in what may be the next multibillion-dollar merger to shake the global pharmaceutical industry. Report
> Shire expects to feel little if any impact from an FDA investigation into the safety of hyperactivity medicines, scheduled for release early next year. Item
> Novo Nordisk has launched an iPhone app for U.S. healthcare professionals that enables them to look up dosing guidelines for their patients with diabetes. Article
> Lawyers suing drug maker Bayer claim they have good reasons to investigate a product they haven't sued over, but their reasons remain secret. Article
Biotech News
@FierceBiotech: Bluebird in spotlight after gene therapy cures blood disorder. Article | Follow @FierceBiotech
> Cell Therapeutics gets OK to sell more shares. News
> Crucell eagerly accepts $2.3B buyout offer from J&J. Story
> Transition, Lilly kill diabetes program after trial failure. Article
> Arena fails to convince FDA panel on obesity drug. News
> Burrill to Minnesota: No ink on that $1B biopark contract. Report
> Explosive Chinese market inspires new Merck pact on personalized meds. Story
And Finally... Pfizer is looking to make more bucks from Fido, Fifi and farm animals. Report